Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotypeGiulio Metro, Lucio Crinò, Rita Chiari et al.|Lung Cancer|2012Cited by 70
Emerging drugs for small cell lung cancer – an updateGiulio Metro, Lucio Crinò, Simona Duranti et al.|Expert Opinion on Emerging Drugs|2012Cited by 20
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast CancerStefania Gori, Luca Boni, Maria Giovanna Cavazzini et al.|PLoS ONE|2015Cited by 13
Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast CancerStefania Gori, Luca Boni, Alessandro Inno et al.|PLoS ONE|2015Cited by 3